Ultra-Violet Fluorescence Bronchial Cancer Location

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diagnose lung cancer at an early stage is crucial for effective treatment. At these early stages, cancer is usually invisible in ambient white light when the endoscopic analysis of the bronchial mucosa. This lining is self-fluorescent at its illumination by blue light. These widely distributed autofluorescence methods detect early mucosal abnormalities. They are very sensitive but not specific to recognize the lung cancer. Thanks to European funding (EURIMUS), a new tool with fluorescent UV light has been developed.

The purpose of this preliminary study is to verify the suitability for specific detection of cancerous tissue in Pneumology of this fluorescence method versus histological analysis of the tissue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hd-bronchoscopy, Comparison to Standard White Light and Autofluorescence Bronchoscopy

NCT01676012

Cancer

COMPLETED

Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease

NCT00241267

Pulmonary Neoplasms

TERMINATED

Spectrum Analysis in Ex-vivo Human Lungs

NCT03356743

Lung Cancer

COMPLETED NA

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

NCT05526573

Lung Cancer Lung; Node Lung Diseases +3 more

RECRUITING

Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases

NCT00377338

Respiratory Tract Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with lung cancer

Group Type EXPERIMENTAL

Rigid bronchoscopy with ultraviolet transmission

Intervention Type PROCEDURE

Biopsy

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rigid bronchoscopy with ultraviolet transmission

Intervention Type PROCEDURE

Biopsy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient affiliated or entitled to a social security scheme
* Major Patient
* Patient who signed the informed consent document
* Patient with a known primary cancer in bronchial level